May 8 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2019 Mar 31, 2018 Mar 31, 2020 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 4.67 4.39 5.00 2.40
(+6.5 pct) (-6.7 pct) (+7.0 pct) (+6.4 pct)
Operating 581 mln 456 mln 550 mln 250 mln
(+27.4 pct) (-3.9 pct) (-5.4 pct) (-18.6 pct)
Recurring 596 mln 477 mln 550 mln 250 mln
(+25.0 pct) (+2.0 pct) (-7.8 pct) (-23.0 pct)
Net 385 mln 277 mln 380 mln 180 mln
(+38.9 pct) (-10.3 pct) (-1.5 pct) (-18.0 pct)
EPS 98.57 yen 66.49 yen 103.00 yen 48.79 yen
Ann Div 15.00 yen 12.50 yen 15.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 15.00 yen 12.50 yen 15.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T